Skip to main content
Signal8

Ticho Barry

SEC insider (Form 3/4/5 filer). CIK 0001780088. CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK). 70 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in BEDFORD, MA.

Companies Ticho Barry has filed insider reports for

  • Stoke Therapeutics, Inc. (STOK): Officer, CHIEF MEDICAL OFFICER
Ticho Barry profile photo

Ticho Barry

CIK: 0001780088

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)48 (68.6%)

Position reduction

Option Exercises (M)16 (22.9%)

Derivative conversions

Awards (A)6 (8.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Stoke Therapeutics, Inc. logo
STOK

Stoke Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (70 total)

  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Oct 1, 2026
    Sale
    Direct
    1.1K shares at avg. $26.16$27K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Sep 1, 2026
    Sale
    Direct
    1.6K shares at avg. $31.06$50K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Sep 1, 2026
    Sale
    Direct
    3.9K shares at avg. $30.51$120K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Aug 18, 2026
    Sale
    Direct
    4.5K shares at avg. $32.01$145K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Aug 18, 2026
    Sale
    Direct
    242 shares at avg. $32.47$8K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Aug 14, 2026
    Exercise
    Direct
    10K shares-
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Aug 3, 2026
    Sale
    Direct
    1.3K shares at avg. $29.45$37K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Aug 3, 2026
    Sale
    Direct
    5.9K shares at avg. $28.95$171K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Jul 1, 2026
    Sale
    Direct
    6.7K shares at avg. $32.62$219K
  • Stoke Therapeutics, Inc. logo
    STOK

    Stoke Therapeutics, Inc.

    Jul 1, 2026
    Sale
    Direct
    500 shares at avg. $33.27$17K

1-10 of 70

…